The Lancet
All the latest articles published on Lancet Journal Discussion Group https://t.me/Medical_Professionals_Forum Contact us https://t.me/Contact_Updates_in_Medicine_Bot
- 24 hours
- +4
- 7 days
- +44
- 30 days
- –
- Reactions
- 0
- Reposts
- 0
- Comments
- 0
Subscriber growth
The Lancet has 18,234 subscribers. A typical post is seen by about 351 people within a day, an engagement rate of 1.9%.
Daily numbers, last 30 days
| Date | Subscribers | Change | Posts | Avg. post views |
|---|---|---|---|---|
| 11 Nov | 18,234 | +4 | 4 | 382 |
| 10 Nov | 18,230 | +6 | 3 | 405 |
| 9 Nov | 18,224 | +7 | 8 | 429 |
| 8 Nov | 18,217 | +29 | 1 | 611 |
| 4 Nov | 18,188 | +245 | 0 | – |
| 4 Oct | 17,943 | – | 0 | – |
Views as a post ages
Average views at each age, posts of the last 30 days.
- 1 h
- 39
- 3 h
- 149
- 6 h
- 165
- 12 h
- 250
- 24 h
- 345
- 48 h
- 420
- 3 days
- 390
When it posts
Times in UTC. 36 posts in 90 days.
Recent posts
-
[Articles] Trevogrumab (anti-GDF8) with or without garetosmab (anti-activin A) for prevention of muscle loss during semaglutide-induced weight reduction in people with obesity (COURAGE): a two-part, phase 2, double-blind, placebo-controlled, randomised trial https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)01953-7/fulltext?rss=yes This study establishes proof of concept for GDF8 inhibition by trevogrumab alone as a generally well tolerated strategy to preserve lean mass during GLP-1 receptor agonist-induced weight loss. Although the addition of ActA inhibition by garetosmab further improved body composition and weight loss, the combination did not have favourable safety an...
176 views -
[Articles] Infection and inflammation as risk factors for post-stroke cognitive impairment and dementia: a systematic review and meta-analysis https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(26)00581-X/fulltext?rss=yes Post-stroke infection is associated with increased risk of PSCID, with SVD potentially conferring increased susceptibility. Inflammatory biomarker associations suggest a role for BBB damage and immune activation. However, available evidence cannot distinguish an infection-specific effect in PSCID from infection-associated inflammation, stroke-induced sterile inflammation, or their combination.
309 views -
[Comment] A digital intervention to strengthening parenting in Tanzania https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)02198-7/fulltext?rss=yes Preventing children's exposure to hardship, trauma, and abuse in childhood is a global public health priority. This exposure is associated with a substantial burden of disease and is one of the most important risk factors for experience and perpetration of violence against women, with all the entailed health consequences.1–3 Over recent years, research on and development of interventions to prevent child abuse and neglect through strengthening of parenting have intensified. Reviews show considerable success with some intervention...
464 views 1 Reactions -
[Review] Reframing disease elimination: an update from the Lancet Commission on chronic obstructive pulmonary disease https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)01947-1/fulltext?rss=yes Chronic obstructive pulmonary disease (COPD) remains a leading cause of morbidity and mortality worldwide, with increasing global burden driven by population growth and ageing, persistent harmful exposures, and substantial health inequities. The Lancet Commission on COPD articulated an ambitious vision for disease elimination with prevention, early detection, and intervention. This Review revisits that vision, assesses progress since 2022, and calls for a broader commitment to lifelon...
412 views -
[Articles] A blended digital parenting intervention for the prevention of sexual violence, exploitative sex, and maltreatment of children at scale in Tanzania: a cluster-randomised, controlled trial https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)01819-2/fulltext?rss=yes A low-cost blended digital parenting programme in countries such as Tanzania could simultaneously reduce childhood sexual violence (for girls) and maltreatment and sexual violence risk situations (for girls and boys).
344 views -
[Articles] National burden of lung cancer in Kazakhstan: a 10-year cohort study https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(26)00568-7/fulltext?rss=yes Our estimates reflect the escalating public health challenges in Kazakhstan. LC is primarily diagnosed in advanced stages, making preventive measures particularly important.
382 views 1 Reactions 1 Reposts -
[Articles] Two-step deep learning for candidemia prediction using time-series electronic health record data from the USA: a model development and validation study https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(26)00520-1/fulltext?rss=yes A two-step deep-learning framework integrating candidemia and mortality risk may support early identification of high-risk patients and facilitate timely empiric antifungal therapy. Prospective studies are warranted to confirm the findings.
397 views -
[Review] Targeting the PI3K/AKT/mTOR pathway in endocrine-resistant, hormone receptor-positive, HER2-negative, advanced breast cancer https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(26)00573-0/fulltext?rss=yes Combination treatment with endocrine therapy and cyclin-dependent kinase 4/6 (CDK 4/6) inhibitors is the standard first-line treatment for hormone receptor-positive, human epidermal growth factor receptor 2 (HER2)-negative, advanced/metastatic breast cancer. However, mechanisms of resistance to endocrine therapy plus CDK4/6 inhibitors, mostly classified as alterations involving activation of cell cycle mediators or alternative signalling axes such as the PI3K/AKT/mTOR...
436 views 1 Reposts -
[Articles] Efficacy and safety of efinopegdutide in adults with metabolic dysfunction-associated steatohepatitis and stage 2–3 fibrosis: a phase 2b, randomised, placebo-controlled study https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)02043-X/fulltext?rss=yes Treatment with efinopegdutide resulted in a significantly greater proportion of participants with MASH resolution without worsening of fibrosis compared with placebo. The 7 mg dose showed the most favourable benefit–risk profile, improving fibrosis by at least one stage without worsening steatohepatitis in approximately half of participants after 1 year of treatment. These findings support the potential utility of efi...
500 views 1 Reposts -
[Comment] Efinopegdutide: a step towards precision in MASH therapy? https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)02193-8/fulltext?rss=yes The global impact of metabolic dysfunction-associated steatohepatitis (MASH) across diverse populations is significant. MASH cirrhosis has become a leading indication for liver transplantation and a primary driver of hepatocellular carcinoma. Advanced MASH fibrosis is associated with increased all-cause mortality and a nearly two-times increased risk of extrahepatic malignancies.1
431 views 1 Reposts
-
[Clinical Rounds] Vertigo, multifocal brain lesions, and a diagnostic clue on the skin https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)00695-1/fulltext?rss=yes A woman aged 35 years was evaluated for a 1-year history of recurrent, brief (approximately 15 min) episodes of non-positional vertigo described as a spinning sensation. Episodes were not accompanied by headache, tinnitus, hearing loss, visual symptoms, or other neurological complaints. Blood pressure was normal, and there was no orthostatic hypotension or tachycardia upon standing. Neurological and vestibular examinations, including audiometry and the Dix–Hallpike manoeuvre, were normal between episodes.
681 views 1 Reactions -
[Comment] Preparing for dialysis when dialysis might never begin? https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)02004-0/fulltext?rss=yes For older people (aged ≥80 years) with frailty or multimorbidity living with kidney failure, choosing a care pathway could involve deciding whether to prepare for dialysis long before it is needed. Preparation involves education, appointments, investigations, and, for some people, surgery to create dialysis access. The alternative care pathway is conservative kidney management, which involves active care aimed at slowing kidney disease progression, managing symptoms, and preserving quality of life without planning for dialysis.
653 views -
[Seminar] Eating disorders https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)01326-7/fulltext?rss=yes The eating and feeding disorders are serious psychiatric disorders at the mind–body interface, often with an exceptionally high burden for affected individuals, their families and supporters, and wider society. In anorexia nervosa, high acute medical risk and patients’ ambivalence about treatment can make a challenging combination that can impede engagement. First-line treatments for eating disorders are mainly psychological, with medications playing an adjunctive role. Novel biological and technology-based interventions are only slowly emerging.
632 views -
[Articles] Cangrelor versus crushed ticagrelor in acute myocardial infarction complicated by cardiogenic shock (DAPT-SHOCK-AMI): a randomised, double-blind trial https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)00976-1/fulltext?rss=yes To our knowledge, this is the first randomised trial to compare P2Y12 inhibitor strategies specifically in patients with AMI-CS. Cangrelor achieved effective platelet inhibition more frequently than crushed ticagrelor at the end of primary percutaneous coronary intervention. Non-inferiority of cangrelor versus crushed ticagrelor was not demonstrated for the primary 30-day clinical endpoint. These trial findings can inform future trials of P2...
611 views -
[Articles] Smoking and dementia risk: an updated systematic review and meta-analysis of 61 prospective cohort studies and implications for tobacco control https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(26)00563-8/fulltext?rss=yes Current smoking is consistently associated with higher risk of all dementia outcomes and increases with smoking intensity. Estimates refer to clinically diagnosed dementia syndromes [Diagnostic and Statistical Manual of Mental Disorders/International Classification of Diseases (DSM/ICD)] and not to biologically defined disease. Although causality cannot be established from observational data, these findings support considering dementia and brain he...
578 views 2 Reactions -
[Articles] Effect of a mHealth intervention on detectable HIV-1 viral load: a remote randomised controlled trial https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(26)00580-8/fulltext?rss=yes A scalable, mHealth application significantly reduced odds of detectable VL in the short-term, primarily by preventing virologic rebound.
572 views -
[Correspondence] Global health: dying from failure or fulfilment? https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)02119-7/fulltext?rss=yes Richard Horton asks whether global health can recover its lost radicalism, referring to Saul Alinsky's Reveille for Radicals.1 Alinsky's ideas also reached Japan, where the book was translated and published in 1972.2 This Japanese translation arrived at precisely a moment when questions of citizen participation, organisation, and power had unusual resonance in Japan amid growing citizen movements against industrial pollution and other social problems.
571 views -
[Articles] Efficacy and safety of efinopegdutide in adults with metabolic dysfunction-associated steatohepatitis and stage 2–3 fibrosis: a phase 2b, randomised, placebo-controlled study https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)02043-X/fulltext?rss=yes Treatment with efinopegdutide resulted in a significantly greater proportion of participants with MASH resolution without worsening of fibrosis compared with placebo. The 7 mg dose showed the most favourable benefit–risk profile, improving fibrosis by at least one stage without worsening steatohepatitis in approximately half of participants after 1 year of treatment. These findings support the potential utility of efi...
500 views 1 Reposts -
[Correspondence] Women with obstetric fistula in Somalia deserve better https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)02028-3/fulltext?rss=yes Obstetric fistula is a devastating morbidity that rightly merits investigation and advocacy, as attempted in the World Report by Clotilde Bigot.1 However, we are dismayed by the quality of this reporting, which did not fact check the claims of its single source. The report does not meet the rigorous editorial standards that we expect from The Lancet. It does a disservice to vulnerable women who have obstetric fistula in Somalia and beyond.
493 views -
[Comment] A digital intervention to strengthening parenting in Tanzania https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)02198-7/fulltext?rss=yes Preventing children's exposure to hardship, trauma, and abuse in childhood is a global public health priority. This exposure is associated with a substantial burden of disease and is one of the most important risk factors for experience and perpetration of violence against women, with all the entailed health consequences.1–3 Over recent years, research on and development of interventions to prevent child abuse and neglect through strengthening of parenting have intensified. Reviews show considerable success with some intervention...
464 views 1 Reactions
Questions about The Lancet
How many subscribers does The Lancet have?
The Lancet (@the_lancet) has 18,234 subscribers as of November 12, 2026.
How many people see a post on The Lancet?
A typical post gets about 350 views within 24 hours, roughly 2% of its subscribers (the ERR).
What is The Lancet about?
It is listed in Health, and posts mostly in English. The channel describes itself as: “All the latest articles published on Lancet Journal Discussion Group https://t.me/Medical_Professionals_Forum Contact us https://t.me/Contact_Updates_in_Medicine_Bot”
Where does The Lancet rank?
By subscribers it is #49 in Health, #1,195 among English channels, #1,466 worldwide.
Does The Lancet post ads?
None of its 36 posts in the last 30 days carried an ad label such as #ad or Sponsored. Unlabelled promotions can’t be detected.
Statistics updated 34 minutes ago.